These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6181386)

  • 1. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
    Beaujouan JC; Torrens Y; Herbet A; Daguet MC; Glowinski J; Prochiantz A
    Mol Pharmacol; 1982 Jul; 22(1):48-55. PubMed ID: 6181386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.
    Beaujouan JC; Torrens Y; Viger A; Glowinski J
    Mol Pharmacol; 1984 Sep; 26(2):248-54. PubMed ID: 6207421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.
    Bahouth SW; Stewart JM; Musacchio JM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):116-23. PubMed ID: 6205134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked regional heterogeneity of 125I-Bolton Hunter substance P binding and substance P-induced activation of phospholipase C in astrocyte cultures from the embryonic or newborn rat.
    Beaujouan JC; Daguet de Montety MC; Torrens Y; Saffroy M; Dietl M; Glowinski J
    J Neurochem; 1990 Feb; 54(2):669-75. PubMed ID: 1688922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An isolated growth cone-enriched fraction from developing rat brain has substance P binding sites.
    Lockerbie RO; Beaujouan JC; Saffroy M; Glowinski J
    Brain Res; 1988 May; 468(1):1-9. PubMed ID: 2454147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and characterization of substance P binding sites in rat and rabbit eyes.
    Denis P; Fardin V; Nordmann JP; Elena PP; Laroche L; Saraux H; Rostene W
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1894-902. PubMed ID: 1709627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P receptors in primary cultures of cortical astrocytes from the mouse.
    Torrens Y; Beaujouan JC; Saffroy M; Daguet de Montety MC; Bergström L; Glowinski J
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9216-20. PubMed ID: 2431412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of substance P binding sites in submucous plexus of guinea pig ileum, using whole-mount autoradiography.
    Burcher E; Bornstein JC
    Synapse; 1988; 2(3):232-9. PubMed ID: 2463691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of substance P with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide.
    Sjödin L; Brodin E; Nilsson G; Conlon TP
    Acta Physiol Scand; 1980 May; 109(1):97-105. PubMed ID: 6160731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of a 125I-substance P derivative binding to synaptosomes from various brain structures and the spinal cord of the rat.
    Torrens Y; Beaujouan JC; Viger A; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):134-9. PubMed ID: 6196645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterisation of two tachykinin binding sites in the rat cerebral cortex.
    Torrens Y; Beaujouan JC; Glowinski J
    Neuropeptides; 1985 Mar; 6(1):59-70. PubMed ID: 2581167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells.
    Cooke HJ; Fox P; Alferes L; Fox CC; Wolfe SA
    Can J Physiol Pharmacol; 1998 Feb; 76(2):188-93. PubMed ID: 9635159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular substance P binding to normal and inflamed rat and human synovium.
    Walsh DA; Salmon M; Mapp PI; Wharton J; Garrett N; Blake DR; Polak JM
    J Pharmacol Exp Ther; 1993 Nov; 267(2):951-60. PubMed ID: 7504102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic study of substance P analogs. I. Evaluation of peptides synthesized by the multipin method for quantitative receptor binding assay.
    Wang JX; Bray AM; Dipasquale AJ; Maeji NJ; Geysen HM
    Int J Pept Protein Res; 1993 Oct; 42(4):384-91. PubMed ID: 7503963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A; Palma C; Manzini S; Werge TM
    Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced [125I]-Bolton Hunter substance P binding (NK1 receptors) in the basal forebrain nuclei of aged rats.
    Geraghty DP; Maguire CM
    Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1112-5. PubMed ID: 12390300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and quantification of (125)I-bolton hunter substance P binding sites in human brain.
    Nilsson L; Winblad B; Volkmann I; Alafuzoff I; Bergström L
    Neurochem Int; 1991; 18(3):399-404. PubMed ID: 20504717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of physalaemin, substance P, and eledoisin with specific membrane receptors on pancreatic acinar cells.
    Jensen RT; Gardner JD
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5679-83. PubMed ID: 230488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanine nucleotides decrease the affinity of substance P binding to its receptor.
    Luber-Narod J; Boyd ND; Leeman SE
    Eur J Pharmacol; 1990 Apr; 188(4-5):185-91. PubMed ID: 1694776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.